Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Lilly expects 25% growth, Novo sees its sales drop in 2026; Amgen turns down FDA request to withdraw rare disease drug

In this week’s Phispers, we bring you the split story of two GLP-1 drugmakers — Eli Lilly and Novo Nordisk. While L...

Impressions : 532

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

Public health suffered several setbacks over the last week. First, the United States formally exited the World Health Organiza...

Impressions : 1244

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

In 2022, Pfizer had crossed US$ 100 billion in revenue owing to its Covid products. While that was a one-off, Johnson & Johnson...

Impressions : 1140

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

This week’s Phispers is packed with news from the ongoing JP Morgan Healthcare Conference (JPM26). Notably, AbbVie said i...

Impressions : 1143

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly expects 25% growth, Novo sees its sales drop in 2026; Amgen turns down FDA request to withdraw rare disease drug

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

Qilu Pharm Hainan's Generics Carboplatin Receives Approval in US

Avyxa's Vykoura Receives Approval in US

Qilu Pharm's Generics Doxorubicin HCl Receives Approval in US

Kindos' Generics Selenious Acid Receives Approval in US

Novitium Pharma's Generics Mirtazapine Receives Approval in US

Apotex's Generics Fidaxomicin Receives Approval in US

Long Grove Pharms' Generics Estradiol Receives Approval in US

Cipla's Generics Lenalidomide Receives Approval in US

Zydus' Generics Dapagliflozin Receives Tentative Approval in US

Vis' Yuvezzi Receives Approval in US

Enforcement Report - Week of February 4, 2026

Panacea Biotec Limited Fails EDQM Inspection

FD A Issues Form 483 toUS Specialty Formulations

Hebei Shengxue Dacheng Pharmaceutical Fails EDQM Inspection

Hangzhou Yiqi Biotechnology is on FDA Import Alert List

FDA Issues Form 483 to InnoStar Bio-Tech Nantong

FDA Issues Form 483 to JKR Pharmacy Ventures

Enforcement Report - Week of January 28, 2026

Center For Immunology's Receives FDA Warning Letter

Fulijaya Manufacturing SDN BHD's Receives FDA Warning Letter

Sun Pharma To Pump In Rs 500 Cr In Assam Manufacturing Unit

Satellos Announces Canada-US IPO, Nasdaq Filing

Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

Illumina Releases 2025 Q4 And Fiscal Year Financials

FDA Proposes Waiving GDUFA Fees for Domestic Facilities

Neuland Labs Joins LIR Life Sciences In Phase 2 Peptide Design

NICE Recommends Dupilumab For Severe CRSwNP In England & Wales

Breckenridge Announces Strategic Collaboration with Medichem

Trumprx Website Set To Launch Thursday Evening After Delay

Bayer's Asundexian Shows 26% Stroke Reduction

FDA Proposes Waiving GDUFA Fees for Domestic Facilities

Hims & Hers Plans To Launch $49 Copy Of Wegovy Pill

Lupin Introduces Topiramate Extended-Release Capsules In US

Zydus Receives USFDA Tentative Approval For Dapagliflozin Tablets

NATCO Receives Fda's Tentative Approval For Erdafitinib Tablets

National Pharmaceutical Pricing Authority Sets Retail Prices

Lupin Launches Dasatinib Tablets In The United States

Indoco Remedies Gets USFDA Nod To Sell Generic Epilepsy Medicine

Alembic Gets USFDA Nod For Difluprednate Ophthalmic Emulsion

U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing

Satellos Announces Canada-US IPO, Nasdaq Filing

Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

Neuland Labs Joins LIR Life Sciences In Phase 2 Peptide Design

NICE Recommends Dupilumab For Severe CRSwNP In England & Wales

Biodexa Announces Exclusive License of Otsuka's OPB-171775

AstraZeneca Wins CDSCO Nod for Durvalumab in Gastric Cancer

Zelluna ASA: To Host Q4 2025 Results Webcast

Veradermics Locks In $256M IPO, Shares Spike

Vaxcyte To Present At Guggenheim Emerging Outlook Biotech Summit

Ultragenyx To Host Q4 2025 Financial Results Conference Call

Sun Pharma To Pump In Rs 500 Cr In Assam Manufacturing Unit

Fis Successfully Completes €770 Million Bond Issuance

Wanbury Reaches First Sales Invoicing Shipment Milestone

Piramal Pharma Solutions Launches Tablet-In-Capsule Services

Lilly Drafts Plan For Last Of 4 New US Drug Manufacturing Plants

FDA Launches Program to Boost Domestic Drug Manufacturing

Wanbury Reveals Tanuku API Facility, Aims For Rs. 100 Crore

Minimum Import Price Set For Penicillin G, Salts

Beyond the Label What Defines Pharma-Grade Mupirocin Calcium API

What a World-Class API Manufacturing Facility Looks Like

Novo Nordisk Addresses Hims & Hers' Illegal Compounding

FDA Warns Drug, Device Makers For CGMP Violations

DGFT Amends Import Policy On Penicillin To Boost Trade

AICDF Warns Sanofi India On Trade Policy Changes

EU Body's Advice on Toxin Limit in Baby Formula Prompts Recalls

Doctor Is 1st to Face Private Lawsuit Under Abortion Drug Ban

Aquestive Therapeutics Receives FDA Complete Response Letter

Health Ministry Proposes Pregabalin For Schedule H1 Inclusion

Pondicherry Recalls 3 Batches of Substandard Drugs

Haryana FDA Conducts Large-Scale Raid On Fatehabad Pharmacies

Nexalin Launches NeuroCare for Alzheimer's and Mood Disorders

University Of West England Implements Heartsciences' Myovista

Aetna Introduces Digital-First Benefits Onboarding For Members